Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CV Sciences (CVSI) Equity Average (2016 - 2025)

Historic Equity Average for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to $1.7 million.

  • CV Sciences' Equity Average fell 2887.85% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 2887.85%. This contributed to the annual value of $2.3 million for FY2024, which is 12097.84% up from last year.
  • Latest data reveals that CV Sciences reported Equity Average of $1.7 million as of Q3 2025, which was down 2887.85% from $1.8 million recorded in Q2 2025.
  • CV Sciences' Equity Average's 5-year high stood at $11.6 million during Q1 2021, with a 5-year trough of $294000.0 in Q4 2022.
  • Moreover, its 5-year median value for Equity Average was $2.6 million (2024), whereas its average is $4.1 million.
  • Per our database at Business Quant, CV Sciences' Equity Average crashed by 9599.59% in 2022 and then skyrocketed by 98537.41% in 2023.
  • Over the past 5 years, CV Sciences' Equity Average (Quarter) stood at $7.3 million in 2021, then crashed by 96.0% to $294000.0 in 2022, then skyrocketed by 985.37% to $3.2 million in 2023, then plummeted by 37.54% to $2.0 million in 2024, then dropped by 16.16% to $1.7 million in 2025.
  • Its Equity Average was $1.7 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.8 million in Q1 2025.